The relationship between pharmaceutical and biopharmaceutical companies and drug delivery system manufacturers has evolved over the past 20 years. In the past, the relationships were purely transactional, but this has changed over the last two decades.
Significant innovation in disease treatment, including the increased focus on complex biologic therapies1, has resulted in important industry trends that have had an impact on many aspects of aseptic processing.
While the requirements for serialization in the pharmaceutical supply chain are generally regarded as inevitable counterfeiting is simply too large of a problem to not be addressed there is some uncertainty around the specifics,particularly globally.
Digital technology has been driving change throughout the life science industry for years, however the sector is currently standing on the precipice of revolutionary development – some organizations have already taken the jump towards a more digital future.
The Falsified Medicines Directive 2011/62/EU, which is due for adoption in February 2019, will require pharmaceuticalcompanies to apply serialisation codes to every applicable pack (OTC and some minor exemptions).
Interview & Whitepapers
News & Press Releases
UBM India, India's leading B2B exhibition organizer, is all set to bring in the third edition of the widely appreciated India Pharma Week (IPW), a week-long celebration packed with avant-garde events from December 10-14, 2018 alongside its flagship expo CPhI & P-MEC India (December 12-14, 2018) to North India.
Progressive Care Inc. , a personalized healthcare services and technology company, launched a new program designed to educate patients and providers on treatment alternatives to opioids available through the company.
According to ISO annual survey published in November 2017, 1,025,761 certificates were issued based on ISO 9001:2008 but only 80,596 certificates based on the new ISO 9001:2015 during 2016.
Global contract manufacturing organisation, Orion Contract Manufacturing, has signed a commercial supply agreement with Peptonic Medical for the manufacture and packaging of its patented product, VagiVital®.
On 25 June 2018, Lonza, in collaboration with Kirkstall Ltd., a biotechnology company based in Rotherham (UK), is hosting a free 60-minute webinar on the development of more physiologically relevant 3D lung-immune cell models for enhanced disease modeling.
STA Pharmaceutical Co., Ltd. (WuXi STA), a subsidiary of WuXi AppTec, announces that its partner, Ascletis has received approval from China Food and Drug Administration (CFDA) of its Category 1 new drug, Ganovo® (also known as Danoprevir or ASC08), to treat viral hepatitis C.
- 04 September 2018 - 07 September 2018
- Hynes Convention Center, Boston, MA
- 19 June 2018 - 21 June 2018
- Amba Hotel Marble Arch
- London, UK
- 10 April 2018 - 11 April 2018
- The Hotel Brussels, Brussels
- 11 April 2018 - 13 April 2018
- National Exhibition and Convention Center,
- 02 May 2018 - 06 May 2018
- Barcelona, Spain
ADC Biotechnology (ADC Bio) predicts that the next crucial phase of innovation to optimise and streamline production processes of ADCs will be designed at the clinical development stage by specialist, ADC focused service providers.
Biogen and Neurimmune announced that Biogen has exercised its option to further reduce the previously negotiated royalty rates payable on potential future sales of aducanumab, Biogen’s Phase 3 investigational treatment for early Alzheimer’s disease.
IDIFARMA has announced new GMP spray drying capabilities which will make it one of the very few contract development and manufacturing organisations (CDMO) to offer spray drying technology for highly potent drugs up to Category 4 OEL/OEB.
MEI Pharma, Inc a pharmaceutical company focused on leveraging its extensive development and oncology expertise to identify and advance new therapies for cancer.
AstraZeneca and MedImmune, its global biologics research and development arm, announced top-line results from the GALATHEA Phase III trial for Fasenra (benralizumab) in patients with moderate to very severe COPD .
Planegg (pta/08.05.2018/07:30) Medigene AG (MDG1, Frankfurt, Prime Standard), announced that researchers from Max-Delbrück-Center for Molecular Medicine (MDC) and Charité, both in Berlin, Germany, will present an update on the clinical trial preparations concerning a MAGE-A1-specific T cell receptor clinical investigator-initiated trial (IIT) at the 16th Cancer Immunotherapy Conference (CIMT) in Mainz, Germany, from 15 - 17 May.
Medical technology company IME Technologies, developer, producer and scientific partner in the field of biomedical electro spinning processes and equipment, has moved its operations from Geldrop to a significantly larger facility in Waalre with effect from 26 March.
Switzerland-based contract development and manufacturing organisation (CDMO) Micro-Sphere has successfully completed the Swissmedic inspection of its expanded facility, resulting in the renewal of its GMP approved status and increased manufacturing capacity.
Robert Bosch Packaging Technology GmbH reports a stable business development for the past fiscal year.
Global contract packaging organisation, Tjoapack, has signed a five-year agreement with Photocure for the packaging of its proprietary bladder cancer detection products.
Product life cycle management (PLM) is now a critical area of focus for any pharmaceutical marketer. It’s no longer enough to simply get a drug to market – maintaining success, meeting different market requirements and profitability throughout its life is just as important.